Yazar "Sahbudak Bal, Zumrut" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    Acute Suppurative Perichondritis After Helix Piercing in a Child
    (Lippincott Williams & Wilkins, 2024) Ozer, Emine Cigdem; Avcu, Gulhadiye; Arslan, Asli; Ekemen, Coskun; Sahbudak Bal, Zumrut
    Transcartilaginous ear piercing has be come increasingly popular among teen agers in the last decade. Because of the unique avascular nature of ear cartilage, it re ceives its nutrition from the perichondrium.
  • Küçük Resim Yok
    Öğe
    Garre’s Osteomyelitis of the Jaw in a Child: Report of a Case Treated with Colchicine
    (2023) Özden Yüce, Meltem; Sahbudak Bal, Zumrut; Güner Özenen, Gizem; Bilen, Nimet Melis; Kurugol, Zafer; Ozkınay, Ferda; Yıldırım Arslan, Sema
    Garre’s osteomyelitis is a rare chronic inflammatory disease with reactive peripheral bone formation due to low-grade local infection. Here, we present a 12-year-old female with chronic osteomyelitis and proliferative periostitis with no definite source of infection, such as caries or periodontitis. The patient had a history of 4-5 hospitalizations with the same symptoms intermittently over the previous two years at the hospital which referred her to our hospital. The patient had undergone a biopsy at the referring hospital, and she was referred to our hospital with a histopathological diagnosis of osteoid osteoma. Physical examination showed a unilateral swelling in the right mandible at admission to our hospital. Since we could not exclude the diagnosis of bacterial osteomyelitis, antibiotics were continued. Periapical radiography, magnetic resonance, computed tomography, and clinical features supported the diagnosis of Garre’s osteomyelitis, so antimicrobial therapy was discontinued. Her biopsy materials were re-examined by the pathologist at our hospital, and Garre’s osteomyelitis was considered. Non- steroidal anti-inflammatory drugs were started. We added colchicine treatment because she failed to achieve remission, and normal facial symmetrical morphology was not achieved in the two-month follow-up period. However, the symptoms regressed within one year, and the swelling disappeared.
  • Küçük Resim Yok
    Öğe
    SARS-CoV-2 reinfections in the pediatric cohort-a single-center experience
    (Oxford Univ Press, 2023) Arslan, Asli; Sahbudak Bal, Zumrut; Erci, Ece; Yildirim Arslan, Sema; Bilen, Nimet Melis; Avcu, Gulhadiye; Cicek, Candan
    Background This study focused on timelines of infection episodes and dominant variants and aims to determine disease severity and outcome of pediatric patients with reinfection.Materials and Methods This study retrospectively evaluated the medical records of the hospitalized patients and/or outpatients aged 0-18 with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction between March 2020 and September 2022 at Ege University Children's Hospital.Results Ninety-one pediatric patients reinfected with SARS-CoV-2 were included in the study. There was an underlying disease in 26.4% of the patients. The median time between the two infection episodes was 184 (90-662) days. There were 24 patients (26.3%) with the first infection in pre-Delta period; 17 (18.6%) of them were reinfected in Omicron BA.1 period, while 7 (7.6%) in Omicron BA.4/BA.5 period. Forty-five patients (49.4%) were infected initially in the Delta period; 35 patients (38.4%) were reinfected in the Omicron BA.1 period, while 10 patients (10.9%) were reinfected in the Omicron BA.4/BA.5 period. Twenty-two patients (24.1%) had the first infection in the Omicron BA.1 period and then reinfected in the Omicron BA.4/BA.5 period. Patients with reinfection more frequently displayed a symptom (84.6% vs. 94.5%, p = 0.03). The hospitalization rate significantly declined in reinfection (15.3% vs. 7.6%, p = 0.03). Severe disease, treatment needs and steroid use were decreased in reinfections without a significant difference (p > 0.05). Intensive care unit admission was not altered.Conclusion This study revealed that reinfections frequently develop in previously healthy children but do not cause more severe outcomes. The risk of symptomatic reinfections is still high due to the effect of the Omicron variant.